EFG International’s China Pharma Holdings CPHI Stock Holding History

EFG International’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26	Hold	40	–	–	﹤0.01%	1087
2026 Q1	$24	Hold	40	–	–	﹤0.01%	1038
2025 Q4	$48	Buy	+40	New	+$66	﹤0.01%	868

Other funds holding CPHI

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

EFG International's CPHI Position: Q2 2026 in Review

EFG International held its China Pharma Holdings (CPHI) position steady in Q2 2026 at 40 shares worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

EFG International first reported a position in CPHI in Q4 2025 and has held it in 3 quarters since. The position peaked at $48 in Q4 2025. 8 funds tracked by Wall St. Rank hold CPHI as of Q2 2026.

EFG International held 40 shares of China Pharma Holdings worth $26 as of Q2 2026.
EFG International left its China Pharma Holdings share count unchanged in Q2 2026.
China Pharma Holdings made up ﹤0.01% of EFG International's portfolio in Q2 2026, its #1087 holding.
EFG International first reported a position in China Pharma Holdings in Q4 2025 and has held it in 3 quarters since.
EFG International's China Pharma Holdings position peaked at $48 in Q4 2025.
8 funds tracked by Wall St. Rank held China Pharma Holdings as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.